- Rare diseases
- Experimental models
- Delivery of therapies
- Engineered Allele Validation Workshop
Yale School of Medicine, United States
"Mouse models as an entry point for understanding gene regulatory variation and its effects on traits within and across species"
Matthew T. Maurano
NYU Medical Center, United States
- Hans Tómas Björnsson, Iceland
- Annique Claringbould, Germany
- Illana Gozes, Israel
- Marián Hajdúch, Czechia
- Hana Hanzlikova, Czechia
- Marcello Maresca, Sweden
- Axel Schambach, Germany
- Ras Trokovic, Finland
- Jan Tuckermann, Germany
- Luca Varani, Switzerland
- Norbert Weiss, Czechia
It is my great pleasure to invite you to the fifth CCP Phenogenomics Conference.
The scientific committee has selected the topic of rare diseases: experimental models & delivery of therapies as the main thematic focus of this year Conference.
We believe that the Conference will provide again an excellent opportunity to support networking and interactions among the researchers, CCP staff, users and experts from the commercial sector.
We are looking forward to meeting you either in Prague or virtually in September 2023.
Director of the Czech Centre for Phenogenomics
Institute of Molecular Genetics of the Czech Academy of Sciences
Czech Centre for Phenogenomics (CCP)
CCP is a large research infrastructure unique in combining genetic engineering capabilities, advanced phenotyping and imaging modalities, SPF animal housing and husbandry, as well as cryopreservation and archiving, all in one central location – at BIOCEV campus.
Through its membership in INFRAFRONTIER and IMPC, CCP is a partner in a global network that aims to comprehensively and systematically analyze the effect of loss of function gene mutations in mice. The goal is to produce a comprehensive ‘encyclopedia‘ of gene function, that will help identify causative factors of human diseases as well as novel targets for therapeutic intervention.